Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Atreca to Present at Upcoming Virtual Investor Conferences
-
Walden Biosciences Announces Virtual Presentation at Canaccord Genuity 41st Annual Growth Conference
-
Zeta to Present at Upcoming Investor Conferences
-
Teladoc Health to Participate in Canaccord Genuity Growth Conference
-
Atreca to Present at Upcoming Virtual Investor Conferences
-
Blue Apron to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
Sage Therapeutics to Present at Upcoming August Investor Conferences
-
REPAY to Attend Canaccord Genuity 41st Annual Growth Conference on August 12, 2021
-
Boxed to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
Nuvei to Participate in Upcoming Investor Conferences
-
Boxed to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
X4 Pharmaceuticals to Participate at Canaccord Genuity’s Virtual 41st Annual Growth Conference
-
Cree, Inc. to Participate in Canaccord Genuity’s 41st Annual Growth Conference
-
SailPoint To Participate in Canaccord Genuity 41st Annual Growth Conference
-
Zoominfo to Participate in Upcoming Investor Conference
-
Calyxt to Present at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021
-
ChemoCentryx to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
ChemoCentryx to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
Hamilton Thorne to Present at Canaccord Genuity 41st Annual Growth Conference
-
Hamilton Thorne to Present at Canaccord Genuity 41st Annual Growth Conference
-
Neoleukin Therapeutics to Participate in Canaccord Genuity 41st Annual Growth Conference
-
Cortexyme to Present at Canaccord Genuity' s 41st Annual Growth Conference on August 11th
-
Better Therapeutics, Inc. to Present at the Canaccord Genuity’s 41st Annual Growth Conference
-
AgroFresh Solutions to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Neoleukin Therapeutics to Participate in Canaccord Genuity 41st Annual Growth Conference
-
Theratechnologies to Present at the Canaccord Genuity 41st Annual Growth Conference
-
BlackBerry to Participate in Upcoming Investor Conferences
-
Curaleaf Announces Presentation at the Canaccord Genuity 41st Annual Growth Conference
-
EQ Inc. to Present at Canaccord Genuity Annual Growth Conference
-
Theratechnologies to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
-
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
-
Zynerba Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Zynerba Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference
-
CloudMD to Present at the Canaccord Genuity Growth Conference
-
Form 8.3 - [Marlowe plc - 03 08 2021] - (CGWL)
-
Form 8.3 - [Restore plc - 03 08 2021] - (CGWL)
-
Curaleaf Holdings, Inc. (CURLF) Announces Presentation at the Canaccord Genuity 41st Annual Growth Conference
-
Quarterhill to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Canaccord Genuity Group Inc. Reports First Quarter Fiscal 2022 Results
-
Impinj to Participate in Upcoming Investor Conferences
-
Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
-
BlackSky to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Terns Pharmaceuticals to Present at Upcoming Investor Conferences
-
Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
-
Minim to Present at Upcoming Virtual Investor Conferences
-
Minim to Present at Upcoming Virtual Investor Conferences
-
Terns Pharmaceuticals to Present at Upcoming Investor Conferences
-
Dynatronics Corporation Will Participate in Canaccord Genuity 41st Annual Growth Conference, August 10-12, 2021
-
Ameresco (AMRC) PT Lowered to $73 at Canaccord Genuity, Following Earnings

